Raj Chakraborty: Benefits of Antibody Drug Conjugates for Multiple Myeloma

By Raj Chakraborty, MD - Last Updated: November 14, 2022

Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, speaks about the benefits of antibody drug conjugates (ADC) for multiple myeloma.

Advertisement

Post Tags:MM
Advertisement
Advertisement
Advertisement